NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
7.53
Dollar change
+0.26
Percentage change
3.51
%
Index- P/E- EPS (ttm)-4281.00 Insider Own0.20% Shs Outstand0.58M Perf Week5.84%
Market Cap4.38M Forward P/E- EPS next Y-12.13 Insider Trans0.00% Shs Float0.58M Perf Month14.19%
Enterprise Value-10.38M PEG- EPS next Q-2.26 Inst Own0.01% Short Float2.41% Perf Quarter-37.91%
Income-6.70M P/S87.57 EPS this Y99.81% Inst Trans27.87% Short Ratio0.37 Perf Half Y-99.35%
Sales0.05M P/B0.28 EPS next Y13.97% ROA-65.63% Short Interest0.01M Perf YTD-99.42%
Book/sh27.10 P/C0.30 EPS next 5Y- ROE-72.53% 52W High3499.51 -99.78% Perf Year-99.73%
Cash/sh25.37 P/FCF- EPS past 3/5Y60.35% 40.18% ROIC-42.44% 52W Low6.20 21.37% Perf 3Y-99.99%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-8.81% 11.20% Gross Margin-434.53% Volatility6.22% 5.69% Perf 5Y-
Dividend TTM- EV/Sales-207.63 EPS Y/Y TTM92.91% Oper. Margin-10493.70% ATR (14)0.72 Perf 10Y-
Dividend Ex-Date- Quick Ratio21.64 Sales Y/Y TTM-9.07% Profit Margin-12266.48% RSI (14)45.40 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio21.64 EPS Q/Q99.77% SMA205.64% Beta1.31 Target Price20.00
Payout- Debt/Eq0.00 Sales Q/Q87.77% SMA505.50% Rel Volume1.51 Prev Close7.27
Employees6 LT Debt/Eq0.00 EarningsMay 28 SMA200-98.92% Avg Volume38.09K Price7.53
IPOApr 22, 2022 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume57,604 Change3.51%
Jun-25-25 06:00AM
Jun-24-25 07:00AM
Jun-10-25 06:00AM
May-20-25 06:00AM
May-12-25 07:34AM
06:00AM Loading…
May-05-25 06:00AM
Apr-29-25 06:00AM
Apr-23-25 06:00AM
Apr-21-25 06:00AM
Apr-09-25 07:00AM
Apr-02-25 06:00AM
Mar-31-25 07:00AM
Mar-26-25 07:00AM
Mar-13-25 09:25AM
Mar-07-25 09:45AM
09:35AM Loading…
Mar-06-25 09:35AM
Mar-03-25 06:00AM
Feb-28-25 04:01PM
Feb-20-25 12:31PM
06:00AM
Feb-11-25 07:58AM
Feb-06-25 07:23AM
Feb-04-25 07:23AM
Jan-31-25 11:59AM
Jan-30-25 03:13PM
Jan-28-25 10:51AM
Jan-24-25 05:30PM
Jan-17-25 04:43PM
Jan-15-25 09:15AM
Jan-07-25 07:28AM
04:11PM Loading…
Jan-03-25 04:11PM
Dec-03-24 03:45PM
Nov-21-24 08:00AM
Nov-14-24 05:00PM
Oct-10-24 07:00AM
Sep-27-24 06:57AM
Sep-13-24 08:30AM
Sep-12-24 06:57AM
06:00AM
Sep-11-24 01:00PM
06:00AM
Sep-10-24 06:57AM
Sep-06-24 11:27AM
Sep-05-24 06:57AM
Aug-29-24 06:57AM
Aug-21-24 07:57AM
Aug-15-24 09:48AM
Aug-14-24 08:08AM
Aug-13-24 09:07AM
Jul-09-24 07:00AM
Jun-26-24 08:30AM
Jun-25-24 08:30AM
Jun-20-24 08:00AM
Jun-18-24 07:00AM
May-15-24 10:55PM
Apr-29-24 09:00AM
Apr-25-24 09:14AM
Apr-23-24 08:00AM
Mar-04-24 08:00AM
Feb-27-24 03:22PM
Feb-26-24 09:15AM
08:42AM
Feb-05-24 08:00AM
Jan-29-24 09:31AM
09:17AM
Jan-26-24 07:58AM
Jan-22-24 08:00AM
Jan-17-24 08:00AM
Jan-08-24 08:00AM
Jan-02-24 12:00PM
Nov-27-23 08:00AM
Nov-08-23 08:00AM
Nov-06-23 08:00AM
Nov-01-23 08:00AM
Oct-25-23 08:30AM
Oct-24-23 08:45AM
Oct-23-23 07:00AM
Oct-02-23 08:00AM
Aug-25-23 04:10PM
Jun-14-23 11:27AM
Jun-08-23 07:30AM
May-30-23 07:30AM
May-23-23 07:30AM
07:00AM
May-19-23 07:30AM
May-11-23 12:41PM
May-02-23 07:00AM
Apr-28-23 11:20AM
Apr-24-23 07:00AM
Mar-07-23 09:19AM
Feb-16-23 07:00AM
Feb-15-23 07:00AM
Feb-05-23 08:50AM
Jan-31-23 10:01AM
Jan-17-23 08:29AM
08:00AM
Dec-22-22 10:36AM
Dec-21-22 10:23AM
Dec-19-22 08:33AM
Dec-01-22 09:41AM
Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.